Alterations in the proangiogenic functions of adipose tissue-derived stromal cells isolated from diabetic rats

Stem Cells and Development

Volumn 17, Issue 4, 2008, Pages 669-680

  Kim, Hoe Kyu ^a,b   Kim, Yeon Jeong ^a,b   Kim, Jong Tae ^a,b   Kwon, Chae Hwa ^a   Kim, Yong Keun ^a,b   Bae, Yong Chan ^a   Kim, Dong Heon ^a   Jung, Jin Sup ^a,b  

^a Pusan National University School of Medicine   (South Korea)

^b Pusan National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CATALASE; GLUCOSE; MANNITOL; REACTIVE OXYGEN METABOLITE; STREPTOZOCIN;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; DIABETES MELLITUS; INSULIN DEPENDENT DIABETES MELLITUS; LIMB ISCHEMIA; LIPID DIET; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; RAT; STROMA CELL;

MUS MUSCULUS; RATTUS;

EID: 51849101671     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2007.0141     Document Type: Article

References (42)

1. Garcia MJ, PM McNamara, T Gordon and WB Kannel. (1974). Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes 23:105-111.
2. Tepper OM, RD Galiano, JM Capla, C Kalka, PJ Gagne, GR Jacobowitz, JP Levine and GC Gurtner. (2002). Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106:2781-2786.
3. Bentley SA. (1982). Bone marrow connective tissue and the haemopoietic microenvironment. Br J Haematol 50:1-6.
4. Dexter TM. (1982). Stromal cell associated haemopoiesis. J Cell Physiol Suppl l:87-94.
5. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
6. Makino S, K Fukuda, S Miyoshi, F Konishi, H Kodama and J Pan. (1999). Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 103:697-705.
7. Zuk PA, M Zhu, H Mizuno, J Huang, JW Futrell, AJ Katz, P Benhaim, H P Lorenza nd MH Hedrick. (2001). Multilineage cells from human adipose tissue implications for cell-based therapies. Tissue Eng 7:211-228.
8. Safford KM, KC Hicok, SD Safford, YD Halvorsen, WO Wilkison, JM Gimble and HE Rice. (2002). Neurogenic differentiation of murine and human adipose-derived stromal cells. Biochem Biophys Res Commun 294:371-379.
9. Lee RH, B Kim, I Choi, H Kim, HS Choi, KT Suh, YC Bae and JS Jung. (2004). Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem 14:311-324.
10. Kim YJ, YC Bae, KT Suh and JS Jung. (2006). Quercetin, a flavonoid, inhibits proliferation and increases osteogenic differentiation in human adipose stromal cells. Biochem Pharmacol 72:1268-1278.
11. Oswald J, S Boxberger, B Jørgensen, S Feldmann, G Ehninger, M Bornhäuser and C Werner (2004). Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 22(3):377-384.
12. Al-Khaldi A, H Al-Sabti, J Galipeau and K Lachapelle. (2003). Therapeutic angiogenesis using autologous bone marrow stromal cells improved blood flow in a chronic limb ischemia model. Ann Thorac Surg 75:204-209.
13. Miranville A, C Heeschen, C Sengenés, CA Curat, R Busse and A Bouloumié (2004). Improvement of postnatal neovascularization by human adipose tissue-derived stem cells. Circulation 110:349-355.
14. Planat-Benard V, JS Silvestre, B Cousin, M André M Nibbelink, R Tamarat, M Clergue, C Manneville, C Saillan-Barreau, M Duriez, A Tedgui, B Levy, L Pénicaud and L Casteilla. (2004). Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation 109:656-663.
15. Rehman J, D Traktuev, J Li, S Merfeld-Clauss, CJ Temm-Grove, JE Bovenkerk, CL Pell, BH Johnstone, RV Considine and KL March. (2004). Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 109(10):1292-1298.
16. Moon MH, SY Kim, YJ Kim, SJ Kim, JB Lee, YC Bae, SM Sung and JS Jung. (2006). Human adipose tissue derived mesenchymal stem cells improve postnatal neovascularization in a mouse model of hindlimb ischemia. Cell Physiol Biochem 17:279-290.
17. Kim YJ, HK Kim, HH Cho, YC Bae, KT Suh and JS Jung. (2007). Direct Comparison of human mesenchymal stem cells derived from adipose tissues and bone marrow in mediating neovascularization in response to vascular ischemia. Cell Physiol Biochem 20:867-876.
18. Sawant SP, AV Dnyanmote, K Shankar, PB Limaye, JR Latendresse and HM Mehendale. (2004). Potentiation of carbon tetrachloride hepatotoxicity and lethality in type 2 diabetic rats. J Pharmacol Exp 308:694-704.
19. He L, FA Simmen, HM Mehendale, MJ Ronis and TM Badger. (2006). Chronic ethanol intake impairs insulin signaling in rats by disrupting Akt association with the cell membrane. Role of TRB3 in inhibition of Akt/protein kinase B activation. J Biol Chem 281:11126-11134.
20. Klaus S. (2005). Functional differentiation of white and brown adipocytes. Bio Essays 19:215-223.
21. Yu T, JL Robotham and Y Yoon. (2006). Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology. Proc Natl Acad Sci USA 103:2653-2658.
22. Dzau VJ, G Massimiliano, AS Pachori, M Fulvio and LG Melo. (2005). Therapeutic potential of endothelial progenitor cells in cardiovascular diseases. Hypertension 46:7-18.
23. Loomans CJM, de EJP Koening, FJT Staal, MB Rookmaaker, C Verseyden, HC Boer, MC Verhaar, B Braam, TJ Rebelink and A-J van Zonneveld. (2004). Endothelial progenitor cell dysfunction. A novel concept in the pathogenesis of vascular complications of Type I diabetes. Diabetes 53:195-199.
24. Bardell AL and KM Macleod. (2001). Evidence for inducible nitric-oxide synthase expression and activity in vascular smooth muscle of streptozotocin-diabetic rats. J Pharmacol Exp Ther 296:252-259.
25. Sawant SP, AV Dnyanmote, K Shankar, PB Limaye, JR Latendresse and HM Mehendale. (2004). Potentiation of carbon tetrachloride hepatotoxicity and lethality in type 2 diabetic rats. J Pharmacol Exp Ther 308:694-704.
26. Srinivasan K, B Viswanad, L Asrat, CL Kaul and P Ramarao. (2005). Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: A model for type 2 diabetes and pharmacological screening. Pharmacol Res 52:313-320.
27. Reed MJ, K Meszaros, LJ Entes, MD Claypool, JG Pinkett, TM Gadbois and GM Reaven. (2006). A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat protective effect of type 2 diabetes on acetaminophen-induced hepatotoxicity in male Swiss-Webster mice. J Pharmacol Exp Ther 316:507-519.
28. Avram AS, MM Avram and WD James. (2005). Subcutaneous fat in normal and diseased states: 2. Anatomy and physiology of white and brown adipose tissue. J Am Acad Dermatol 53:671-683.
29. Prunet-Marcassus B, B Cousin, D Caton, M André L Pénicaud and L Casteilla. (2006). From heterogeneity to plasticity in adipose tissues: site-specific differences. Exp Cell Res 312:727-736.
30. Kolf CM, E Cho and RS Tuan. (2007). Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther 9:204.
31. Li M, PM Absher, P Liang, JC Russell, BE Sobel and NK Fukagawa. (2001). High glucose concentrations induce oxidative damage to mitochondrial DNA in explanted vascular smooth muscle cells. Exp Biol Med (Maywood) 226:450-457.
32. El-Khatib M, NS Radin and JA Shayman. (1996). Glycosphingolipid synthesis and proliferation in a renal cell line grown in high glucose. Am J Physiol 270:476-484.
33. Baumgartner PS, L Wagner, M Pettermann, J Grillari, A Gessl and W Waldhaus. (1995). High-glucose-triggered apoptosis in cultured endothelial cells. Diabetes 44:1323-1327.
34. Spotiropoulou PA, SA Perez, M Salagianni, CN Baxevanis and M Papamichail. (2006). Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells 24:462-471.
35. Salameh A, M Zinn and S Dhein. (1997). High D-glucose induces alterations of endothelial cell structure in a cell-culture model. J Cardiovasc Pharm 30:182-190.
36. Tianzheng Yu, L James, L Robotham and Y Yoon. (2006). Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology. Proc Natl Acad Sci USA 103:2653-2658.
37. Takeshi N and A Eiichi. (2007). Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications. Antioxid Redox Signal 9:343-353.
38. Cllaghan MJ, JC Daniel and GC Gurtner. (2005). Hyperglycemia-induced reactive oxygen species and impaired endothelial progenitor cell function. Antioxid Redox Signal 7:1476-1482.
39. Ebrahimian TG, H Christophe, Y Dong, BB Olivier, M Barend, W Ludovic, D Micheline, V José RP Brandes, BI Levy, AM Shah and JS Silvestre. (2006). NADPH oxidase-derived overproduction of reactive oxygen species impairs postischemic neovascularization in mice with type i diabetes. Am J Pathol 169:719-728.
40. Sagun KC, JM Cárcamo and WG David. (2005). Vitamin C enters mitochondria via facilitative glucose transporter 1 (Glut1) and confers mitochondrial protection against oxidative injury. FASEB J 19:1657-1667.
41. Recchioni R, F Marcheselli, F Moroni and C Pieri. (2002). Apoptosis in human aortic endothelial cells induced by hyperglycemic condition involves mitochondrial depolarization and is prevented by N-acetyl-L-cysteine. Metabolism 51:1384-1388.
42. Chen YH, SJ Lin, FY Lin, TC Wu, CR Tsao, PH Huang, PL Liu, YL Chen and JW Chen. (2007). High glucose impairs early and late endothelial progenitor cells by modifying nitric oxide-related but not oxidative stress-mediated mechanisms. Diabetes 56:1559-1568.